Update on avian influenza A (H5N1) virus infection in humans
about
Transmission dynamics of the recently-identified BYD virus causing duck egg-drop syndromeSeasonal oscillation of human infection with influenza A/H5N1 in Egypt and IndonesiaNew class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferretsInfluenza virus antigenic variation, host antibody production and new approach to control epidemicsHuman influenza A H5N1 in Indonesia: health care service-associated delays in treatment initiationThe DNA-damage response in human biology and diseasePredominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparednessMemory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsLive attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenzaComplexities in Ferret Influenza Virus Pathogenesis and Transmission ModelsAvian Influenza Viruses, Inflammation, and CD8(+) T Cell ImmunitySystems biology from virus to humansAntibody-Based Strategies to Prevent and Treat InfluenzaUse of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza virusesGlobal alert to avian influenza virus infection: from H5N1 to H7N9H5N1 vaccines in humansEffect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferretsA drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases.Emerging and Zoonotic Infections in WomenInnate immunity to influenza virus: implications for future therapyGeneral Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007X-ray structure of NS1 from a highly pathogenic H5N1 influenza virusA Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 HemagglutininRisk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivirViral Infection in the Development and Progression of Pediatric Acute Respiratory Distress SyndromePrevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-AnalysisInhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion proteinInfluenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern VietnamOseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenzaImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primatesWhat is the optimal therapy for patients with H5N1 influenza?Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with OseltamivirEffect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trialInteraction of avian influenza virus NS1 protein and nucleolar and coiled-body phosphoprotein 1Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumoniaN-glycans from porcine trachea and lung: predominant NeuAcα2-6Gal could be a selective pressure for influenza variants in favor of human-type receptorExploring cell tropism as a possible contributor to influenza infection severityEffectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in ChinaPoint-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.
P2860
Q21134857-735D56F8-0B72-40D2-AAC1-061962E961ABQ21135246-77C71FF2-BDCE-4733-81E1-C82223D72971Q21142658-5EF77D8B-7F92-49FF-BA98-B743E8DB63CDQ21245119-EC353AAB-E47C-42CA-9555-35A88D9E2EBEQ21257264-0F190D1B-8B69-45D3-AC57-EBDB81D6D247Q24606586-C0352569-177C-434B-AC9E-C639FD70264FQ24647318-CDA3C3AB-D87A-4418-8AED-0C8F8E9D5FE2Q24648051-CE0F37C1-30A3-4F45-91D6-330232A36BE6Q24652088-989D643A-3577-4A3E-98DC-91993E5B3256Q26740459-9CE027A3-B417-4578-9D97-8642BB25B2C3Q26765927-1582E3B4-432C-4B34-B58C-12663D7F14F6Q26798272-E02134E9-0E81-4DF7-8296-CDC5C2F7883AQ26798520-607B34C1-C744-40BD-8D09-35F9214DCBE8Q26859435-5750153C-FC11-4F6D-B651-3DC9B5B527F8Q26864488-FCBF3C60-087C-4C5F-94D8-9B583FC13E45Q27000896-689C755B-8D70-41EA-B65C-CC34535EDF9CQ27314689-7C865547-B94A-47A5-8BA7-30617D237C05Q27324423-492BDC4A-BAC9-4533-85C7-1FD12081361DQ27334466-97C59C23-77D0-4748-88A6-C4D8EDDBFB81Q27487976-BC25FD3F-5514-47D5-BC9F-488EA0BD2910Q27489605-5CFF1971-EDC5-4F05-B53A-B1E94362B5DFQ27490512-EB314993-17E4-4B4A-8092-3123EA856F18Q27652788-00FD4294-097A-49D4-BEB8-E346F42485A3Q27679987-80E83FF0-CCD0-4CBD-89E5-83B23EE27599Q28066861-6B798151-B81B-4FD5-91DB-18DAA9EF53E3Q28071857-B6328A31-E3D3-4608-92D1-D52CF90165F1Q28357789-00B42E3B-2044-47D5-9E6B-47E085FED9F1Q28471835-5D2299EF-BC7E-42D0-8BA7-AFC5E7F3B176Q28473743-2F65694A-CEA0-43C3-BBC7-BE7D10F3DD94Q28473860-6E765A0A-59AA-4FDF-A9F2-C8CF13ED22ACQ28475369-8C053E88-84B7-4F48-87C5-6D2F2E1F18C1Q28475630-34656BB2-267C-4CA0-8815-557A414CD3CDQ28548533-61E0DF9F-DFC4-4CA2-91D9-AE55C41FC9ABQ28684866-DE21B248-1CA5-41E5-AD2A-944BBEF95594Q28709524-1C5B0625-0899-4EA2-BEAC-1994F7CC21EBQ28732374-2C8CF99B-1A41-4EAF-90B6-8BF5209439F3Q28742944-A3834CFF-00D5-4300-93DC-C5588A80265BQ28748187-754F0F01-C147-4B92-AA41-7891520D4F69Q28749090-90FC4CFB-A00A-42A6-9872-7220A84E4663Q30204573-DBD0D0DB-81CF-4440-BC4D-4E39278CC0F8
P2860
Update on avian influenza A (H5N1) virus infection in humans
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Update on avian influenza A (H5N1) virus infection in humans
@ast
Update on avian influenza A (H5N1) virus infection in humans
@en
Update on avian influenza A (H5N1) virus infection in humans
@nl
type
label
Update on avian influenza A (H5N1) virus infection in humans
@ast
Update on avian influenza A (H5N1) virus infection in humans
@en
Update on avian influenza A (H5N1) virus infection in humans
@nl
prefLabel
Update on avian influenza A (H5N1) virus infection in humans
@ast
Update on avian influenza A (H5N1) virus infection in humans
@en
Update on avian influenza A (H5N1) virus infection in humans
@nl
P2093
P50
P3181
P356
P1476
Update on avian influenza A (H5N1) virus infection in humans
@en
P2093
Abdel-Nasser Abdel-Ghafar
Azim Naghdaliyev
Duc Hien Nguyen
Menno D de Jong
Nahoko Shindo
Santoso Soeroso
Zhancheng Gao
P304
P3181
P356
10.1056/NEJMRA0707279
P407
P577
2008-01-17T00:00:00Z